Global AI In Oncology Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global AI In Oncology Market Research Report 2024
The application of AI in cancer practice includes providing clinical decision support for cancer diagnosis and screening, processing medical data for cancer detection or characterization of patient prognosis, and optimizing care delivery and clinical operations by increasing system capacity and allocating resources.
According to MRAResearch’s new survey, global AI In Oncology market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole AI In Oncology market research.
Artificial intelligence(AI) in oncology helps in faster and accurate diagnosis of cancer which helps to deliver better patient outcomes and this is anticipated to drive the growth of the market during the forecast period. Growing advancements in the healthcare infrastructure and the increasing prevalence of cancer are some of the key factors that are projected to drive market growth during the forecast period.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global AI In Oncology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Azra AI
IBM
Siemens Healthineers
Intel
GE Healthcare
NVIDIA
Digital Diagnostics Inc.
Concert.AI
Median Technologies
Path AI
Segment by Type
Software Solutions
Hardware
Services
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Brain Tumor
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The AI In Oncology report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global AI In Oncology market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole AI In Oncology market research.
Artificial intelligence(AI) in oncology helps in faster and accurate diagnosis of cancer which helps to deliver better patient outcomes and this is anticipated to drive the growth of the market during the forecast period. Growing advancements in the healthcare infrastructure and the increasing prevalence of cancer are some of the key factors that are projected to drive market growth during the forecast period.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global AI In Oncology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Azra AI
IBM
Siemens Healthineers
Intel
GE Healthcare
NVIDIA
Digital Diagnostics Inc.
Concert.AI
Median Technologies
Path AI
Segment by Type
Software Solutions
Hardware
Services
Segment by Application
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Brain Tumor
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The AI In Oncology report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source